NYSE: CTEVClaritev Corp Stock
$20.08-0.24 (-1.18%)
Updated Apr 17, 2025
CTEV Price
$20.08
Fair Value Price
N/A
Market Cap
$325.26M
52 Week Low
$4.80
52 Week High
$31.01
P/E
-0.2x
P/B
3.87x
P/S
0.26x
PEG
N/A
Dividend Yield
N/A
Revenue
$930.62M
Earnings
-$1.65B
Gross Margin
74.3%
Operating Margin
-155.2%
Profit Margin
-176.9%
Debt to Equity
60.3
Operating Cash Flow
$108M
Beta
1.19
Next Earnings
May 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CTEV Overview
Churchill Capital Corp III is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations and has not generated any revenue.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CTEV's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
CTEV
Ranked#36 of 44
Ranked#36 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important CTEV news, forecast changes, insider trades & much more!
CTEV News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CTEV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CTEV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CTEV is poor value based on its book value relative to its share price (3.87x), compared to the US Health Information Services industry average (3.39x)
P/B vs Industry Valuation
CTEV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CTEV due diligence checks available for Premium users.
Valuation
CTEV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.2x
Industry
11.14x
Market
27.98x
CTEV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.87x
Industry
3.39x
CTEV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CTEV's financial health
Profit margin
Revenue
$232.1M
Net Income
-$138.0M
Profit Margin
-59.4%
CTEV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CTEV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.2B
Liabilities
$5.1B
Debt to equity
60.3
CTEV's short-term liabilities ($213.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTEV's long-term liabilities ($4.85B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTEV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CTEV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$33.4M
Investing
-$30.4M
Financing
-$3.6M
CTEV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CTEV vs Health Information Service Stocks
Claritev Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.